Tom Wilemon Archive — Page 1 of 40

Medical illustration of the lungs and airways, showing multiple clustered, bubble-like growths in both lungs.
March 20, 2026

Study shows AI-assisted risk model for lung nodules is cost-effective

Risk prediction software using artificial intelligence can help determine whether pulmonary nodules detected during lung cancer screening need to be biopsied.

Promotional flyer for “The Future of Lung Cancer Care,” a lung cancer conference on Friday, May 8, 2026, hosted by Vanderbilt-Ingram Cancer Center and Vanderbilt Lung Institute in Nashville. The flyer includes venue and accreditation details alongside an illustration of lungs with highlighted tumor-like areas.
March 10, 2026

Lung cancer conference set for May 8

Vanderbilt-Ingram Cancer Center and the Vanderbilt Lung Institute will host “The Future of Lung Cancer Care,” a one-day educational event scheduled for May 8 from 8:30 a.m. to 2:30 p.m. at the Nashville Marriott at Vanderbilt University.

Matt Pack, a pharmacy technician manager, stands in an aisle between shelves of prescription medication bottles in a pharmacy.
March 6, 2026

Matt Pack leads efforts to expand opportunities for adults with developmental disabilities

Through his work with Project SEARCH, Pack is helping expand career pathways and build a culture of belonging across Vanderbilt Health.

Olalekan Oluwole, MBBS, MPH, in a suit, stands beside Douglas Johnson, MD, MSCI, in a white medical coat, in a hospital corridor.
February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

3D medical illustration of a syringe dispensing small blue and green Y-shaped antibody forms among larger blue and green molecular structures against a red background.
January 12, 2026

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

(iStock image)
January 8, 2026

Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment 

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.